What is LFVN's market cap?

$75.16M, based on the Nov 4 close of $5.97.

What is LFVN's P/E ratio?

14.8× trailing-twelve-month earnings of $5.07M.

Does Lifevantage Corporation Common Stock (Delaware) pay a dividend?

Yes. The latest regular dividend was $0.05 per share (ex-date Sep 1), an annualised yield of 3.35%.

How much of LFVN is sold short?

976.1K shares, 9.5% of float, as of Oct 15, 2026.

What sector is LFVN in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · LFVNHealthcarePharmaceuticals

Lifevantage Corporation Common Stock (Delaware) (LFVN)

$5.97+3.65%

Close Nov 4, 2026 · split-adjusted

Nov 3, 2026$5.76▼ 21.53% in range

Nov 3, 2025Low $4.02 · High $10.70Nov 3, 2026

What changed · written from our data

As of Nov 4, 2026

Lifevantage Corporation Common Stock (Delaware) closed at $5.97 on Nov 4, up 3.65%, 44.2% below its 52-week closing high. Volume of 20.6K shares was 0.79× its 20-day average (below normal).

Split-adjusted performance: -1.2% over one month, -0.5% over six months, -18.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $42.38M, down 23.1% from a year earlier, with a net margin of 3.0%.

Short interest was 976.1K shares at the Oct 15 settlement, down 8.6% from the prior report (9.5% of float, 28.8 days to cover).

Market cap$75.2M12.6M shares

Revenue · quarter$42.4M−23.1% YoY

Diluted EPS$0.10−33.3% YoY

P/E · TTM14.8×P/S 0.4×

Net margin3.0%Gross 78.0%

Dividend yield3.35%$0.05 last paid

52-week range4.02 – 10.70−44.2% from high

Volume20.6K0.79× 20-day avg

Volatility · 60d26.1%Annualised

Short % of float9.5%28.8 days to cover

Net cash$14.9MCash $14.9M

Next earnings—Not scheduled

Split-adjusted performance

1W +1.4%1M −1.2%3M −9.3%6M −0.5%YTD −3.1%1Y −18.7%3Y −22.7%5Y −7.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum72

Revenue growth27

Net margin71

Value (low P/E)55

Size38

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short976.1K−8.6% vs prior

Days to cover28.8Settled Oct 15

% of float9.5%

Short vol. 10d42.8%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
LFVNLifevantage Corporation Common Stock (Delaware)	$5.97	+3.65%	−0.5%	−23.1%	3.0%	14.8	$75.2M
ACRVAcrivon Therapeutics	$1.74	+4.19%	−16.7%	—	—	—	$74.6M	Compare
FTLFFitLife Brands	$8.18	+3.68%	−12.1%	+64.6%	7.3%	12.3	$76.8M	Compare
COYACoya Therapeutics	$3.08	−0.96%	−27.4%	+49.0%	−2723.4%	—	$72.3M	Compare
MNOVMedicinova	$1.45	+2.11%	0.0%	+240.6%	−504.8%	—	$71.4M	Compare
PMVPPMV Pharmaceuticals	$1.33	−3.99%	−8.6%	—	—	—	$70.8M	Compare
MAIAMAIA Biotechnology	$1.14	+5.56%	−15.6%	—	—	—	$70.4M	Compare
CRBPCorbus Pharmaceuticals Holdings	$3.57	−7.75%	−67.3%	—	—	—	$69.0M	Compare
TENXTenax Therapeutics	$1.81	−1.63%	−84.9%	—	—	—	$67.7M	Compare

News about Lifevantage Corporation Common Stock (Delaware)

All news →

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026GlobeNewswire Inc. · Sep 18, 2026Neutral LifeVantage Declares Quarterly DividendBenzinga · May 6, 2026Neutral

Quick answers

What does Lifevantage Corporation Common Stock (Delaware) do?: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product.
What is LFVN's market cap?: $75.16M, based on the Nov 4 close of $5.97.
What is LFVN's P/E ratio?: 14.8× trailing-twelve-month earnings of $5.07M.
Does Lifevantage Corporation Common Stock (Delaware) pay a dividend?: Yes. The latest regular dividend was $0.05 per share (ex-date Sep 1), an annualised yield of 3.35%.
How much of LFVN is sold short?: 976.1K shares, 9.5% of float, as of Oct 15, 2026.
What sector is LFVN in?: Healthcare, in the Pharmaceuticals industry.

About Lifevantage Corporation Common Stock (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

HQ: Lehi, UT223 employeesListed Mar 10, 1997lifevantage.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology